Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-16-018441)

Filing Details

Accession Number:: 0001179110-16-018441
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-02-03 17:24:31
Reporting Period:: 2016-02-01

Filing Date:: 2016-02-03
Accepted Time:: 2016-02-03 17:24:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145460	Alere Inc.	ALR	In Vitro & In Vivo Diagnostic Substances (2835)	043565120

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1571630	Melissa Guerdan	51 Sawyer Road, Suite 200 Waltham MA 02453	Svp, Global Quality & Reg.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-02-01	2,500	$33.73	2,500	No	4	M	Direct
Common Stock	Disposition	2016-02-01	2,500	$54.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2016-02-01	2,500	$0.00	2,500	$33.73

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,415		2023-10-31	No	4	M	Direct

Footnotes

The sales reported on this Form were made pursuant to a written 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1.
These options become exercisable in four equal annual installments beginning October 31, 2014.
This derivative security does not have a price.